INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease

OBJECTIVE: To evaluate the safety and efficacy of low-dose naproxen for prevention of progression in presymptomatic Alzheimer disease (AD) among cognitively intact persons at risk. METHODS: Investigation of Naproxen Treatment Effects in Pre-symptomatic Alzheimer's Disease (INTREPAD), a 2-year d...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Pierre-François, Tremblay-Mercier, Jennifer, Leoutsakos, Jeannie, Madjar, Cécile, Lafaille-Maignan, Marie-Élyse, Savard, Melissa, Rosa-Neto, Pedro, Poirier, Judes, Etienne, Pierre, Breitner, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Null Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512884/
https://www.ncbi.nlm.nih.gov/pubmed/30952794
http://dx.doi.org/10.1212/WNL.0000000000007232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512884/
https://www.ncbi.nlm.nih.gov/pubmed/30952794
http://dx.doi.org/10.1212/WNL.0000000000007232

Ejemplares similares